|
2006 Research
2005 Index of all Genotype Research
Page One :
2004 Articles
Genotype is the strongest predictor of response to
treatment.
24 weeks of peginterferon alfa-2a plus ribavirin as
effective as 48 weeks with higher-dose ribavirin for HCV genotype 2 and 3
Nov 03 2004
Peginterferon Alfa- 2b
(Peg-Intron) and Ribavirin Combination Therapy in Chronic HCV Genotype 4
Nov 08 2004
SHORT (14 WEEKS)
TREATMENT WITH PEGYLATED INTERFERON ALPHA-2B AND RIBAVIRIN IN PATIENTS WITH
HEPATITIS C GENOTYPE 2/3 VIRUS INFECTION AND EARLY VIROLOGICAL RESPONSE
Nov 01 2004
HCV Genotype 2 and 3 Have Similar SVR to Peginterferon
alfa-2a plus Ribavirin, Regardless of Length of Treatment, Ribavirin Dose,
or Baseline Viral Load
Nov 01 2004
Page Two:
Retreatment of
Interferon Nonresponders with a Reinforced Regimen Should Be Focused on
Genotype 2/3 Patients and Younger Genotype 1/4 Patients
Oct
25 2004
Effects of
Ribavirin Combined with Interferon Alfa on Viral Kinetics in Patients with
HCV Genotype 1 and High Baseline Viral Load
Oct
25 2004
Different
mechanisms of steatosis in hepatitis C virus genotypes 1 and 3 infections
Sep 23 2004
RBV
Kinetics--Improves Early Response
Effects of ribavirin combined
with interferon-alpha2b on viral kinetics during first 12 weeks of treatment
in patients with hepatitis C virus genotype 1 and high baseline viral loads"
Sep 23 2004
Sep 2004
Can You Have
Multiple Genotypes?
Sep 03 2004
HCV Therapy Should Depend on Genotype, Doc Says
Aug 11 2004
NEW YORK (Reuters Health) Jul 02 - Infection with
hepatitis C virus (HCV) genotype 3 often clears spontaneously, sparing the
patient unnecessary treatment, German researchers report in the July issue
of the Journal of Medical Virology.
July 02 2004
Peginterferon
alfa-2b and Ribavirin for 24 Weeks Sufficient for Genotype 2 or 3 Chronic
HCV
June 30 2004
Evidence for a Relation Between the HCV Viral
Load and Genotype and HCV-specific T Cell Responses
June 16 04
Peginterferon Alfa-2b (Peg-Intron) plus Ribavirin Treatment in Previously
Untreated Patients Infected with HCV Genotype 2 or 3
June 02 04
Page Three :
2004 Articles
Infection with Hepatitis C Virus Genotype 4 in the
United States
Cross-Genotype Immunity to Hepatitis C Virus.
HCV Genotype 4
Treatment for Chronic Hepatitis C: Updated Swedish
Consensus Guidelines
HCV Patients with Genotype 1b May Show a Sustained
Response and ALT Improvement After Prolonged Re-treatment with Interferon
Alfa
Efficacy of Early Retreatment with Interferon Beta for
Relapse in Patients with Chronic Hepatitis C Genotype Ib
Is a 48-week Course of Treatment with Peginterferon
Plus Ribavirin Too Short to Maximize a Sustained Viral Response Among
Patients with Hepatitis C virus Genotype 1?
Pegasys plus Copegus: Newly Published Data Reports
Highest Overall Sustained Virological Response Ever - 63%- All Genotypes
Listed
Page Four
2004 Articles
Peginterferon Alfa-2b (PEG-Intron) Plus Ribavirin Can
Cure HCV Genotypes 2 and 3
04-16-04
Schering-Plough Reports New Data Showing Patients with
Hepatitis C Genotypes 2 and 3 May Benefit from Shorter Course of Treatment
with PegIntron and Rebetol Combination Therapy
Black Patients with HCV Genotype 1 in a Study of
Veterans Have a Lower Sustained Viral Response Rate Due to Lower Neutrophil
Count
4-26-04
HCV Genotypes and Pediatric HCV Infection
4-26-04
Twice a Week Administration of PEG-Intron Plus
Ribavirin in Obtaining SVR Among Patients with HCV Genotype 1
May 25 04
|